These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 7619839

  • 21. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
    Shirakawa K, Takara K, Tanigawara Y, Aoyama N, Kasuga M, Komada F, Sakaeda T, Okumura K.
    Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657
    [Abstract] [Full Text] [Related]

  • 22. Fluoroquinolone (ciprofloxacin) secretion by human intestinal epithelial (Caco-2) cells.
    Cavet ME, West M, Simmons NL.
    Br J Pharmacol; 1997 Aug; 121(8):1567-78. PubMed ID: 9283689
    [Abstract] [Full Text] [Related]

  • 23. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
    Pascaud C, Garrigos M, Orlowski S.
    Biochem J; 1998 Jul 15; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
    [Abstract] [Full Text] [Related]

  • 24. Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein.
    Karlsson J, Kuo SM, Ziemniak J, Artursson P.
    Br J Pharmacol; 1993 Nov 15; 110(3):1009-16. PubMed ID: 7905337
    [Abstract] [Full Text] [Related]

  • 25. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
    Horio M, Lovelace E, Pastan I, Gottesman MM.
    Biochim Biophys Acta; 1991 Jan 09; 1061(1):106-10. PubMed ID: 1671642
    [Abstract] [Full Text] [Related]

  • 26. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein.
    Ushigome F, Takanaga H, Matsuo H, Yanai S, Tsukimori K, Nakano H, Uchiumi T, Nakamura T, Kuwano M, Ohtani H, Sawada Y.
    Eur J Pharmacol; 2000 Nov 10; 408(1):1-10. PubMed ID: 11070177
    [Abstract] [Full Text] [Related]

  • 27. Effect of PCB-126 on intracellular accumulation and transepithelial transport of vinblastine in LLC-PK1 and its transformant cells expressing human P-glycoprotein.
    Sasawatari S, Toki M, Horie T, Nakano Y, Ikeda T, Ueda K, Fujise H.
    J Vet Med Sci; 2004 Sep 10; 66(9):1079-85. PubMed ID: 15472471
    [Abstract] [Full Text] [Related]

  • 28. Bodipy-FL-verapamil: a fluorescent probe for the study of multidrug resistance proteins.
    Rosati A, Candussio L, Crivellato E, Klugmann FB, Giraldi T, Damiani D, Michelutti A, Decorti G.
    Cell Oncol; 2004 Sep 10; 26(1-2):3-11. PubMed ID: 15371652
    [Abstract] [Full Text] [Related]

  • 29. Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine.
    Ferry DR, Malkhandi PJ, Russell MA, Kerr DJ.
    Biochem Pharmacol; 1995 Jun 16; 49(12):1851-61. PubMed ID: 7598747
    [Abstract] [Full Text] [Related]

  • 30. Identification of the synthetic surfactant nonylphenol ethoxylate: a P-glycoprotein substrate in human urine.
    Charuk MH, Grey AA, Reithmeier RA.
    Am J Physiol; 1998 Jun 16; 274(6):F1127-39. PubMed ID: 9841506
    [Abstract] [Full Text] [Related]

  • 31. Heat-shock-stimulated transepithelial daunomycin secretion by flounder renal proximal tubule primary cultures.
    Sussman-Turner C, Renfro JL.
    Am J Physiol; 1995 Jan 16; 268(1 Pt 2):F135-44. PubMed ID: 7840240
    [Abstract] [Full Text] [Related]

  • 32. Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents.
    Woodland C, Koren G, Wainer IW, Batist G, Ito S.
    Can J Physiol Pharmacol; 2003 Aug 16; 81(8):800-5. PubMed ID: 12897809
    [Abstract] [Full Text] [Related]

  • 33. Permanent activation of the human P-glycoprotein by covalent modification of a residue in the drug-binding site.
    Loo TW, Bartlett MC, Clarke DM.
    J Biol Chem; 2003 Jun 06; 278(23):20449-52. PubMed ID: 12711602
    [Abstract] [Full Text] [Related]

  • 34. Mediation of cimetidine secretion by P-glycoprotein and a novel H(+)-coupled mechanism in cultured renal epithelial monolayers of LLC-PK1 cells.
    Dudley AJ, Brown CD.
    Br J Pharmacol; 1996 Mar 06; 117(6):1139-44. PubMed ID: 8882608
    [Abstract] [Full Text] [Related]

  • 35. Effect of P-glycoprotein modulators on the human extraneuronal monoamine transporter.
    Martel F, Keating E, Azevedo I.
    Eur J Pharmacol; 2001 Jun 22; 422(1-3):31-7. PubMed ID: 11430910
    [Abstract] [Full Text] [Related]

  • 36. Can the enhanced renal clearance of antibiotics in cystic fibrosis patients be explained by P-glycoprotein transport?
    Susanto M, Benet LZ.
    Pharm Res; 2002 Apr 22; 19(4):457-62. PubMed ID: 12033380
    [Abstract] [Full Text] [Related]

  • 37. P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro.
    Haberl I, Swatonek H, Schaufler K, Ulsperger E, Wenzl E, Theyer G, Hamilton G, Thalhammer T.
    Int J Oncol; 1998 May 22; 12(5):1137-42. PubMed ID: 9538140
    [Abstract] [Full Text] [Related]

  • 38. Epithelial transport of anthelmintic ivermectin in a novel model of isolated proximal kidney tubules.
    Fricker G, Gutmann H, Droulle A, Drewe J, Miller DS.
    Pharm Res; 1999 Oct 22; 16(10):1570-5. PubMed ID: 10554099
    [Abstract] [Full Text] [Related]

  • 39. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
    Ramachandra M, Ambudkar SV, Gottesman MM, Pastan I, Hrycyna CA.
    Mol Biol Cell; 1996 Oct 22; 7(10):1485-98. PubMed ID: 8898356
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.